Initial Serological Response after Prime-boost Pneumococcal Vaccination in Rheumatoid Arthritis Patients: Results of a Randomized Controlled Trial.

CONCLUSION: The early serological response to prime-boost vaccination with PCV13 followed by PPV23 was very similar among participants receiving bDMARD and csDMARD. However, notable differences in response were observed according to individual bDMARD. It is important to consider the RA treatment when planning pneumococcal vaccination in patients with RA. PMID: 28966211 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28966211?dopt=Abstract

Source: J Rheumatol - October 1, 2017 Category: Rheumatology Authors: Nguyen MTT, Lindegaard H, Hendricks O, Jørgensen CS, Kantsø B, Friis-Møller N Tags: J Rheumatol Source Type: research